Global Biotech Leaders Gather in San Francisco for Annual Forum

GenScript Biotech Corporation is set to host its 5th Annual Biotech Global Forum on January 14, 2026, at the San Francisco Marriott Marquis. This year’s event, which offers both in-person and virtual attendance options, coincides with the renowned J.P. Morgan Healthcare Conference. The Forum has established itself as a pivotal platform for collaboration among scientists, innovators, investors, and decision-makers in the biotechnology sector.

The theme of this year’s Forum is ‘Scripting Possibilities’, focusing on how advancements in computational biology and emerging technologies are reshaping cell and gene therapies (CGTs) and next-generation biotherapeutics. Attendees can expect engaging discussions on the latest technologies and collaborations that are transforming the path from scientific discovery to tangible patient benefits.

Sherry Shao, CEO of GenScript Biotech Corporation, emphasized the Forum’s role in uniting leaders from across the biotech landscape. “The Global Forum has become a central gathering point for leaders driving progress across the biotech ecosystem,” she stated. “Our mission is to empower researchers and companies with integrated technologies and expertise, from discovery to development and manufacturing.”

Keynote Speakers and Forum Insights

The event will feature two distinguished keynote speakers whose contributions are shaping the future of biotechnology. They represent a significant intersection of biology and artificial intelligence, where innovative algorithms enhance molecular design and therapeutic strategies.

Dr. Ray Chen, President of GenScript Life Science Group, highlighted the importance of speed, precision, and collaboration in the biotechnology field. “Biotechnology is at an inflection point – where speed, precision, and collaboration are no longer optional,” he said. “The Global Forum is designed to bring together the leaders scripting what comes next and to explore ways of pushing the boundaries of what’s seemingly impossible.”

The program promises to showcase the convergence of discovery science, computational intelligence, and therapeutic development, aiming to accelerate scientific breakthroughs and their application in patient care.

Registration and Company Overview

Registration for the GenScript Biotech Global Forum is now open. Interested participants can find more details and complete their registration through GenScript’s official website.

Founded in 2002 in New Jersey, GenScript Biotech Corporation has been at the forefront of innovation in biotechnology and healthcare. The company provides essential resources to researchers and organizations, facilitating the development of groundbreaking treatments and products. Guided by its mission to enhance health through biotechnology, GenScript supports clients throughout the entire innovation lifecycle, from early discovery to advanced biologics and manufacturing. With a workforce of over 5,700 employees, GenScript has served more than 200,000 customers across over 100 countries and regions.

For further inquiries, media representatives can contact Stefanie Tuck at CG Life via email at [email protected].